Chemed Co. (NYSE:CHE) Shares Sold by North Point Portfolio Managers Corp OH

North Point Portfolio Managers Corp OH trimmed its position in Chemed Co. (NYSE:CHE) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,272 shares of the company’s stock after selling 269 shares during the period. North Point Portfolio Managers Corp OH owned about 0.11% of Chemed worth $8,621,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Bank of Montreal Can boosted its stake in shares of Chemed by 231.3% in the second quarter. Bank of Montreal Can now owns 9,528 shares of the company’s stock worth $5,233,000 after acquiring an additional 6,652 shares during the last quarter. Millennium Management LLC boosted its stake in Chemed by 126.5% during the 2nd quarter. Millennium Management LLC now owns 39,344 shares of the company’s stock worth $21,347,000 after purchasing an additional 21,974 shares during the last quarter. Mackenzie Financial Corp grew its holdings in shares of Chemed by 107.2% during the second quarter. Mackenzie Financial Corp now owns 5,732 shares of the company’s stock worth $3,110,000 after buying an additional 2,966 shares in the last quarter. Algert Global LLC raised its position in shares of Chemed by 10.8% in the second quarter. Algert Global LLC now owns 11,540 shares of the company’s stock valued at $6,261,000 after buying an additional 1,129 shares during the last quarter. Finally, Creative Planning lifted its stake in shares of Chemed by 2.8% in the second quarter. Creative Planning now owns 1,228 shares of the company’s stock worth $667,000 after buying an additional 34 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Trading Up 1.7 %

Shares of CHE opened at $550.99 on Monday. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62. The firm has a market capitalization of $8.29 billion, a P/E ratio of 27.84, a P/E/G ratio of 2.15 and a beta of 0.47. The firm has a 50-day moving average price of $544.24 and a 200 day moving average price of $563.47.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period last year, the company earned $5.32 EPS. Equities research analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were given a $0.50 dividend. The ex-dividend date was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. Chemed’s dividend payout ratio is currently 10.11%.

Analyst Ratings Changes

A number of research firms have commented on CHE. Royal Bank of Canada cut their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the sale, the chief executive officer now directly owns 101,735 shares of the company’s stock, valued at approximately $58,270,755.95. The trade was a 1.93 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Spencer S. Lee sold 732 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the transaction, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at $10,526,362.94. The trade was a 3.85 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.